Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Diabetes related neuropathy diagnosis

Reference number
Coordinator Corpus Data & Image Analysis AB
Funding from Vinnova SEK 21 800
Project duration September 2018 - December 2018
Status Completed

Important results from the project

Diabetes is today an epidemy in the developing countries Most plausible reason is change of Lifestyle (food habits, stressful life etc...) Secondary complications exists such as Neuropathy that might give blindness, slowly healing wounds and at the worst amputation of the lower limbs. Before a cure is found it is of utmost importance to find fast and reliable methods for early detection of neuropathy

Expected long term effects

Corpus, a Swedish R&D company active in Med Tech has developed a product for objective measurement of neuropathy and is now looking for a commercial- as well as a clinical partner for investigating larger patients groups.

Approach and implementation

A Swedish/Chinese consortium of four parties will be formed; two academic (Endocrinology clinics) and two business related companies. The scope of the study will be to measure and compare the two countries results in terms of separation and classification of three categories of patients:1) Healthy2) Diabetes without symptoms of Neuropathy3) Diabetes with serious symptoms of Neuropathy

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 24 October 2018

Reference number 2018-03250

Page statistics